Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | SELL | P14151 | 1/20 | 0.30 |
| ▸ | SELP | P16109 | 1/20 | 0.30 |
| ▸ | SELE | P16581 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | PGK1 | P00558 | 1/20 | 0.30 |
| ▸ | PGK2 | P07205 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15108104 | 0.94 | ALDH1A1 (0.40) | PDE2AALDH1A1TSHRCA1CA9 | |
| SCHEMBL15786432 | 0.84 | ACHE (0.38) | PDE2AACHE | |
| SCHEMBL1966425 | 0.83 | PDE2A (0.39) | PDE2A | |
| SCHEMBL17515293 | 0.82 | PDE2A (0.31) | PDE2A | |
| SCHEMBL17515292 | 0.82 | ALDH1A1 (0.36) | PDE2AALDH1A1 | |
| SCHEMBL21588170 | 0.80 | RAPGEF4 (0.41) | PDE2APGK1PGK2 | |
| SCHEMBL16806445 | 0.77 | CA2 (0.38) | ACHE | |
| SCHEMBL16380967 | 0.77 | ACHE (0.34) | ACHEPGK1PGK2 | |
| SCHEMBL31367042 | 0.77 | CYP2A6 (0.38) | — | |
| SCHEMBL17444932 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11312795-B2 | Transition metal complex for use in or as a catalyst for olefin polymerization | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2022-04-26 | — | — | US | disclosed |
| EP-3630851-B1 | PREPARATION OF POLYMER DISPERSIONS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2021-07-07 | — | — | EP | disclosed |
| US-20200087425-A1 | TRANSITION METAL COMPLEX FOR USE IN OR AS A CATALYST FOR OLEFIN POLYMERIZATION | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2020-03-19 | — | — | US | disclosed |
| US-8653302-B2 | Processes for preparing poly(pentafluorosulfanyl)aromatic compounds | UBE INDUSTRIES, LTD. (JP) | 2014-02-18 | — | — | US | disclosed |
| US-8067625-B2 | Fluorosurfactants | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-11-29 | — | — | US | disclosed |
| US-8049022-B2 | Fluorosurfactants | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-11-01 | — | — | US | disclosed |
| US-20110166392-A1 | Processes for Preparing Poly(Pentafluorosulfanyl)Aromatic Compounds | UBE INDUSTRIES, LTD. (JP) | 2011-07-07 | — | — | US | disclosed |
| US-20100152081-A1 | Fluorosurfactants | MERCK PATENT GMBH (DE) | 2010-06-17 | — | — | US | disclosed |
| US-20090312432-A1 | FLUOROSURFACTANTS | MERCK PATENT GESELLSCHAFT (DE) | 2009-12-17 | — | — | US | disclosed |
| US-20090264525-A1 | FLUOROSURFACTANTS | MERCK PATENT GMBH (DE) | 2009-10-22 | — | — | US | disclosed |
| US-20090197201-A1 | FLUOROSURFACTANTS | MERCK PATENT GESELLSCHAFT (DE) | 2009-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166392-A1 | Processes for Preparing Poly(Pentafluorosulfanyl)Aromatic Compounds | PFAS, PUF60, FES | PDE2A 4852/4885ALDH1A1 4300/4885TSHR 1592/4885 |
| US-20090312432-A1 | FLUOROSURFACTANTS | SGMS2, FASN, SGMS1 | PDE2A 3916/4885ALDH1A1 2479/4885TSHR 1160/4885 |
| US-20100152081-A1 | Fluorosurfactants | CBR3, FPR3, NOX3 | PDE2A 3203/4885ALDH1A1 2466/4885TSHR 886/4885 |
| US-20090264525-A1 | FLUOROSURFACTANTS | FASN, FFAR3, SGMS2 | PDE2A 3945/4885ALDH1A1 2925/4885TSHR 754/4885 |
| US-20090197201-A1 | FLUOROSURFACTANTS | CBR3, SCO2, FPR3 | PDE2A 3630/4885ALDH1A1 3874/4885TSHR 1047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.